Lisa M. Van Baarsen

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals.

Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals.

Journal: Annals of the rheumatic diseases
Published: October 13, 2025

Failing maternal-fetal tolerance in SLE (FaMaLE): a prospective cohort study for finding the molecular mechanisms behind pregnancy complications.

Failing maternal-fetal tolerance in SLE (FaMaLE): a prospective cohort study for finding the molecular mechanisms behind pregnancy complications.

Journal: Lupus science & medicine
Published: May 16, 2025

RA-risk synovium exhibits DNA damage coupled with impaired DNA repair in fibroblasts.

RA-risk synovium exhibits DNA damage coupled with impaired DNA repair in fibroblasts.

Journal: RMD open
Published: April 07, 2025

Enhanced MHC Class-II Expression in Fibroblastic Reticular Cells Associates with Maturation.

Enhanced MHC Class-II Expression in Fibroblastic Reticular Cells Associates with Maturation.

Journal: European journal of immunology
Published: February 27, 2025

Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients.

Divergent gene signatures and neutrophil enrichment in lymph nodes of inflammatory arthritis patients.

Journal: Arthritis research & therapy
Published: February 07, 2025

HLA-DR expressing lymph node fibroblasts maintain FoxP3+ regulatory T cells and are reduced in rheumatoid arthritis.

HLA-DR expressing lymph node fibroblasts maintain FoxP3+ regulatory T cells and are reduced in rheumatoid arthritis.

Journal: Clinical and experimental immunology
Published: January 21, 2025

Lymph nodes as gatekeepers of autoimmune diseases.

Lymph nodes as gatekeepers of autoimmune diseases.

Journal: RMD open
Published: July 30, 2024

The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study.

The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study.

Journal: RMD open
Published: June 05, 2024

Identification and Mapping of Human Lymph Node Stromal Cell Subsets by Combining Single-Cell RNA Sequencing with Spatial Transcriptomics.

Identification and Mapping of Human Lymph Node Stromal Cell Subsets by Combining Single-Cell RNA Sequencing with Spatial Transcriptomics.

Journal: European journal of immunology
Published: April 24, 2024

The key role of the lymph node niche in the development of rheumatoid arthritis.

The key role of the lymph node niche in the development of rheumatoid arthritis.

Journal: Joint bone spine
Published: August 30, 2023

CCL19-Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase.

CCL19-Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 03, 2023

Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target.

Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target.

Journal: Rheumatology (Oxford, England)
Published: December 06, 2022
Showing 1-12 of 39

Last Updated: 09/26/2026